-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-01-27
FFHQDX:NMF-FFHQDX (USD)
MUTUAL FUND | Others |
Last Closing
USD 10.9646Change
0.00 (0.00)%Market Cap
N/AVolume
N/AAnalyst Target
N/AN/A
Verdict
Values as of: 2025-01-27
MUTUAL FUND | Others |
Last Closing
USD 10.9646Change
0.00 (0.00)%Market Cap
N/AVolume
N/AAnalyst Target
N/AN/A
Verdict
Currency:
Country :
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
VRGWX | Vanguard Russell 1000 Growth I.. |
+17.73 (+2.22%) |
USD 26.28B |
XMDYX | Mid Cap SPDR 400 Trust Series .. |
-5.70 (-0.95%) |
USD 19.32B |
VRTIX | Vanguard Russell 2000 Index Fu.. |
+0.74 (+0.21%) |
USD 10.02B |
VRVIX | Vanguard Russell 1000 Value In.. |
-1.97 (-0.59%) |
USD 9.85B |
VRNIX | Vanguard Scottsdale Funds - Va.. |
+4.81 (+0.91%) |
USD 7.05B |
VRTTX | Vanguard Russell 3000 Index Fu.. |
+4.52 (+0.88%) |
USD 3.51B |
XAODX | Alpine Total Dynamic Dividend .. |
-0.08 (-0.83%) |
USD 2.09B |
XNUVX | Nuveen Municipal Value Fd Inc |
+0.04 (+0.43%) |
USD 2.06B |
VRTGX | Vanguard Russell 2000 Growth I.. |
+3.06 (+0.75%) |
USD 1.19B |
XJPCX | Nuveen Preferred Income Opport.. |
+0.01 (+0.13%) |
USD 0.99B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
XMD:CA | iShares S&P/TSX Completio.. | 6.17 % | 0.61 % |
-0.03 (0.00%) |
CAD 0.25B |
WXM:CA | First Asset Morningstar C.. | 3.44 % | 0.67 % |
+0.32 (+0.00%) |
CAD 0.59B |
FIE:CA | iShares Canadian Financia.. | 0.00 % | 0.97 % |
-0.04 (0.00%) |
CAD 1.09B |
FXM:CA | First Asset Morningstar C.. | 0.00 % | 0.67 % |
-0.04 (0.00%) |
CAD 0.30B |
TQCD:CA | TD Q Canadian Dividend ET.. | 0.00 % | 0.00 % |
N/A |
CAD 0.38B |
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
There is nothing we particularly dislike